| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 05/06/2004 | DE10250084A1 Gegen Missbrauch gesicherte Darreichungsform Abuse-proofed dosage form |
| 05/06/2004 | CA2502965A1 Dosage form that is safeguarded from abuse |
| 05/06/2004 | CA2501560A1 Patch and kit containing delayed-type hypersensitivity inducer |
| 05/05/2004 | CN1494451A Regulation of eating habits |
| 05/05/2004 | CN1494435A Preparation for prophylaxis of restenosis |
| 05/05/2004 | CN1148360C Intermediate for preparing cascade polymeric ligand usable as contrast medium |
| 05/04/2004 | US6730477 Includes measuring levels of a breast specific gene (bsg) in cells, tissues or bodily fluids in a patient and comparing to a normal human control |
| 05/04/2004 | US6730300 Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody and use as a tumor vaccine and for targeting applications |
| 05/04/2004 | US6730287 Rapid, low cost drug screening; inducing restorative sleep without side effects |
| 05/04/2004 | US6730037 Vascular catheter having low-profile distal end |
| 05/04/2004 | CA2213638C Aerosols containing nanoparticle dispersions |
| 04/29/2004 | WO2004036182A2 Methods for monitoring treatment of disease |
| 04/29/2004 | WO2004035536A2 Azo compounds for type i phototherapy |
| 04/29/2004 | WO2004035093A2 Polymeric materials for site specific delivery to the body |
| 04/29/2004 | WO2004035091A1 Production of a dye for colouring cells in the human or animal body |
| 04/29/2004 | WO2004035022A2 Prepolymeric materials for site specific delivery to the body |
| 04/29/2004 | WO2004019999A3 Agent delivery particle |
| 04/29/2004 | WO2004011035B1 Bio-degradable microspheres for diagnosing gastroesophagal reflux |
| 04/29/2004 | WO2004010841A3 Method for assessing myocardial angiogenesis |
| 04/29/2004 | WO2003104485A3 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue |
| 04/29/2004 | WO2003103723A3 Neutrophil imaging methods in cyctic fibrosis |
| 04/29/2004 | WO2003090529A3 Methods for identifying and using insecticides |
| 04/29/2004 | WO2003086172A3 Method for tagging colonic residue |
| 04/29/2004 | WO2003038395A8 Remote nmr/mri detection of laser polarized gases |
| 04/29/2004 | WO2003020949A3 Targeted nucleic acid constructs and uses related thereto |
| 04/29/2004 | WO2002072630A3 Nucleic acid-associated proteins |
| 04/29/2004 | WO2002055089A9 Immunoassay technique using multispecific molecules |
| 04/29/2004 | US20040082812 Using amide of a triiodobenzene compound as chemical intermediate |
| 04/29/2004 | US20040082519 Method of treating and diagnosing sleep disordered breathing and means for carrying out the method |
| 04/29/2004 | US20040082499 Perturbed membrane-binding compounds |
| 04/29/2004 | US20040082016 Antibodies specific for papillary fibroblasts as markers for skin quality |
| 04/29/2004 | US20040081994 Measuring efficiency of exercise; measuring isotropic patterns; sensitivity to cardiovascular disorders |
| 04/29/2004 | US20040081971 Gastrointestinal disorders; cardiovascular disorders; autoimmune diseases; cell proliferation; antiinflammatory agents |
| 04/29/2004 | US20040081651 Crystal structure of the complex between one such antibody and the alpha 1-I domain of VLA-1, and to the use of this structural information for computational drug design |
| 04/29/2004 | US20040081622 Absorption, fluorescence of light; diagnosis of kidney, heart diseases |
| 04/29/2004 | US20040081620 Measurement anticoagulant |
| 04/29/2004 | DE10255601A1 Herstellung eines Färbemittels zur Visualisierung von Zellen im menschlichen oder tierischen Körper Preparing a colorant for visualization of cells in the human or animal body |
| 04/29/2004 | CA2502211A1 Azo compounds for type i phototherapy |
| 04/28/2004 | EP1413313A1 DIAGNOSIS AND TREATMENT OF INSULIN−DEPENDENT DIABETES MELLITUS AND INSULITIS |
| 04/28/2004 | EP1412909A1 System and method for quantitative assessment of joint diseases and the change over time of joint diseases |
| 04/28/2004 | EP1412388A1 Humanized antibodies derived from dd-3b6/22, specific for the d-dimer fragment of fibrin |
| 04/28/2004 | EP1412383A2 Peptides conjugates, their derivatives with metal complexes and use thereof for magnetic resonance imaging (mri) |
| 04/28/2004 | EP1412175A1 Insulating and functionalizing fine metal-containing particles with comformal ultra-thin films |
| 04/28/2004 | EP1411992A1 Ionic and non-ionic radiographic contrast agents for use in combined x-ray and nuclear magnetic resonance diagnostics |
| 04/28/2004 | EP1411991A2 Methods of determining the effects of toxins |
| 04/28/2004 | EP1411987A2 Targeted polymeric delivery systems |
| 04/28/2004 | EP1411971A1 Use of long pentraxin ptx3 for treating female infertility |
| 04/28/2004 | EP1073716B1 Improvements in or relating to separation processes |
| 04/28/2004 | EP1017703B1 Pentopyranosyl nucleoside, and production and use of the same |
| 04/28/2004 | EP0935442B1 Instrument having enhanced ultrasound visibility |
| 04/28/2004 | EP0856054B1 Monoclonal antibody br110 and uses thereof |
| 04/28/2004 | EP0784682B1 Novel ectoparasite saliva proteins and apparatus to collect such proteins |
| 04/28/2004 | CN1491641A Porous composite material granular blood vessel embolism agent |
| 04/28/2004 | CN1147584C Modulators of tissue regeneration |
| 04/27/2004 | US6727234 Isoprenoid analog compounds and methods of making and use thereof |
| 04/27/2004 | US6726904 Polyurethane gel mass; lithotripsy and hyperthermia apparatus for therapy |
| 04/27/2004 | CA2116867C Novel chelating agent, complex compound of said chelating agent and metallic atom, and diagnostic agent comprising same |
| 04/22/2004 | WO2004034029A2 Screening systems and methods for identifying modulators of xenobiotic metabolism |
| 04/22/2004 | WO2004033488A2 Peptide mediated synthesis of metallic and magnetic materials |
| 04/22/2004 | WO2004032936A1 Improved imaging agents comprising barbituric acid derivatives |
| 04/22/2004 | WO2004032839A2 Methods and formulations comprising agonists and antagonists of nuclear hormone receptors |
| 04/22/2004 | WO2004032621A2 Techniques for identifying molecular structures and treating cell types lining a body lumen using fluorescence |
| 04/22/2004 | WO2003083102A3 Cancer associated protein phosphatases and their uses |
| 04/22/2004 | WO2003080124A8 Monitoring marker |
| 04/22/2004 | WO2003079921A8 Diagnosis marker |
| 04/22/2004 | WO2003075751A3 Overfeeding methods for determining therapeutic strategies and/or targets for obesity therapeutics |
| 04/22/2004 | WO2003039601A8 Methods for vascular imaging using nanoparticulate contrast agents |
| 04/22/2004 | WO2002092782A3 Diagnosis and treatment of malignant neoplasms |
| 04/22/2004 | US20040077948 Echogenic coatings with overcoat |
| 04/22/2004 | US20040077944 Combined impedance imaging and mammography |
| 04/22/2004 | US20040076627 Humanised antibodies |
| 04/22/2004 | US20040076583 Method for indentification of biologically active agents |
| 04/22/2004 | US20040076582 Comprises spherical/micronized polyvinyl alcohol particle containing radioactive species; monoclonal antibodies |
| 04/22/2004 | US20040076580 For diagnosis/treatment of thrombosis, embolism, atherosclerosis, inflammation or cancer; imaging |
| 04/22/2004 | CA2501872A1 Screening systems and methods for identifying modulators of xenobiotic metabolism |
| 04/22/2004 | CA2501136A1 Improved imaging agents comprising barbituric acid derivatives |
| 04/22/2004 | CA2499318A1 Peptide mediated synthesis of metallic and magnetic materials |
| 04/22/2004 | CA2494231A1 Techniques for identifying molecular structures and treating cell types lining a body lumen using fluorescence |
| 04/21/2004 | EP1411354A1 Method of detecting skin stimulation effect |
| 04/21/2004 | EP1410022A2 Detection and treatment of prostate cancer |
| 04/21/2004 | EP1410014A1 Method for sample identification in a mammal as well as a kit for performing this method |
| 04/21/2004 | EP1409701A2 Fluorescently labelled locked nucleic acids |
| 04/21/2004 | EP1409655A2 Immunoglobulin superfamily proteins |
| 04/21/2004 | EP1409550A1 Extracellular messengers |
| 04/21/2004 | EP1409537A2 Identification of specific tumour antigens by means of the selection of cdna libraries with sera and the use of said antigens in diagnostic imaging techniques |
| 04/21/2004 | EP1409482A2 Dye-sulfenates for dual phototherapy |
| 04/21/2004 | EP1409277A1 Nonskid device for the wheels of vehicles |
| 04/21/2004 | EP1409024A1 Macrocyclic metal complexes and use thereof for production of conjugates with biomolecules |
| 04/21/2004 | EP0800831B1 Diagnostic marker |
| 04/21/2004 | EP0693924B1 Methods for (in vivo) delivery of biologics and compositions useful therefor |
| 04/21/2004 | CN1491118A Parmagnetic nanoparticle |
| 04/21/2004 | CN1146668C Oligonucleotide tags for sorting and identification |
| 04/20/2004 | US6725083 Tissue site markers for in VIVO imaging |
| 04/20/2004 | US6723746 Functional radiographic imaging methods and agents |
| 04/20/2004 | US6723318 Targeting of biomolecules |
| 04/20/2004 | US6723303 Ultrasound contrast agents including protein stabilized microspheres of perfluoropropane, perfluorobutane or perfluoropentane |
| 04/15/2004 | WO2004031725A2 Ratios of collagen peptides, their uses and products |
| 04/15/2004 | WO2004031348A2 Method for convection enhanced delivery of therapeutic agents |
| 04/15/2004 | WO2004031220A1 Tumor targeting agents and uses thereof |
| 04/15/2004 | WO2004014446A9 Embolization |